C
Curt L. Rohlfing
Researcher at University of Missouri
Publications - 45
Citations - 3714
Curt L. Rohlfing is an academic researcher from University of Missouri. The author has contributed to research in topics: Diabetes mellitus & Hemoglobin variants. The author has an hindex of 22, co-authored 45 publications receiving 3467 citations.
Papers
More filters
Journal ArticleDOI
Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.
Curt L. Rohlfing,Hsiao-Mei Wiedmeyer,Randie R. Little,J D England,Alethea L. Tennill,David E. Goldstein +5 more
TL;DR: Knowing the relationship between HbA(1c) and plasma glucose (PG) levels in patients with type 1 diabetes can help patients with diabetes and their healthcare providers set day-to-day targets for PG to achieve specific HBA( 1c) goals.
Journal ArticleDOI
Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.
Curt L. Rohlfing,Randie R. Little,Hsiao Mei Wiedmeyer,J D England,Richard W. Madsen,Maureen I Harris,Katherine M. Flegal,Mark S. Eberhardt,David E. Goldstein +8 more
TL;DR: GHb is a highly specific and convenient alternative to fasting plasma glucose for diabetes screening and could identify a high proportion of individuals with undiagnosed diabetes who are at risk for developing diabetes complications.
Journal ArticleDOI
The National Glycohemoglobin Standardization Program: A five-year progress report
Randie R. Little,Curt L. Rohlfing,Hsiao-Mei Wiedmeyer,Gary L. Myers,David B. Sacks,David E. Goldstein +5 more
TL;DR: The NGSP process is reviewed and progress in standardization is summarized through analysis of CAP data, showing marked improvement over 1993 data in the comparability of GHB results.
Journal ArticleDOI
Status of Hemoglobin A1c Measurement and Goals for Improvement: From Chaos to Order for Improving Diabetes Care
TL;DR: Hb A(1c) is now recommended for diagnosing diabetes, further accentuating the need for optimal assay performance and limiting the ability of clinicians to use these targets.
Journal ArticleDOI
Biological Variation of Glycohemoglobin
Curt L. Rohlfing,Hsiao-Mei Wiedmeyer,Randie R. Little,V. Lee Grotz,Alethea L. Tennill,J D England,Richard W. Madsen,David E. Goldstein +7 more
TL;DR: The biological variation of GHb and fasting plasma glucose (FPG) in nondiabetic individuals is examined and it is suggested that when GHb is used for routine management of patients with diabetes, different patients may require very different GHb target values to achieve the same overall glycemic status.